Operating with a growth mindset

The urgency with which we work enables our organization to build from the great work and culture that has been established our humble start nearly ten years ago.

We proudly remain a nimble biotech focused on challenging areas and novel programs – we are not seeking incremental innovation, but on areas that can have a transformative impact for patients.

Our culture is one that values the team over the individual, bold action and an ability to move quickly. We chart our own path.

Truly listening to the people closest to the challenge is an important part of our success.

As we grow and advance our clinical-stage pipeline and approach commercialization, I like to think we prioritize listening and learning over speaking. Finding the right experts both inside and outside the company is essential to filling important gaps and addressing key risks.

I personally spend time with our new team members to talk about the risks of only relying on what you have done before and ensuring that prior experience is not an impediment to relearning new skills or addressing the unique challenges and opportunities we have. Truly listening to the people closest to the challenge is an important part of our success.

Mirati is filled with individuals who have valuable perspectives that will help us to advance our patient-focused goals, but we must first understand what has been done before. Once we understand, we need to operate with a growth mindset, learn from the lessons that came before us, and progress quickly toward the future.

To me, being relentless means we are not anchored in one place. We are constantly learning, improving and moving forward. My team and fellow colleagues “show up” every day, work hard to achieve our shared goals, and constantly put into action innovative ideas to help patients as quickly as possible.

A culture designed to unleash the potential of our people

“We are purposefully building a collaborative team to tackle the problem of understanding and treating cancer head on,” says Jamie Christensen, chief scientific officer, Mirati Therapeutics, Inc. “Bringing together unique skillsets across translational research and discovery science, we are exclusively and aggressively focused on programs where existing interventions are unknown or insufficient.”

Our labs are set up to be integrated so that all disciplines in R&D can benefit from one another and help rapidly share ideas.

From seating charts to lab configurations, we are aspiring to maximize collaboration, curiosity, and our drive to do more for patients.

“We have an open office setting providing an opportunity to intermingle different functions and teams,” says Jamie. “Our labs are set up to be integrated so that all disciplines in R&D can benefit from one another and help rapidly share ideas.”

The Mirati culture is designed to unleash the potential of our science and our people by creating an environment that fosters open-mindedness and collaboration as we seek to transform the lives of patients with cancer. The company’s more than 320 employees are uniformly focused on patients by trying to make a difference with our science and in our communities.

“Where we differentiate ourselves is that we believe in advancing innovative oncology medicines focused on areas with significant unmet needs. Our portfolio is built on what is right in front us – we simply accept the challenge,” says Jamie. “The goal is to do things in a way that will help solve specific problems for identifiable patients by targeting the genetic and immunological drivers of cancer.”

Read more about our science and how we’re tackling cancer head on.

Bridging R&D and the real world

Kelly Covello, head of Medical Affairs, shares a behind-the-scenes glimpse into the dynamic work of the Mirati Medical Affairs team and how their work intersects with patients, patient advocacy groups and healthcare professionals.


Download the Video

.

.

.

.

Mirati participates as the largest corporate team in Padres Pedal the Cause 2021

Mirati’s mission to discover, design and deliver breakthrough therapies to transform the lives of patients with cancer and their loved ones is well aligned with the Padres Pedal mission of a world without cancer.

For patients with cancer and their families, the Padres Pedal annual event creates connections and shared experiences for survivors, family members and supporters as they raise critical funding to accelerate the search for a cure for cancer.

Cancer research and treatment advances have led to improvements in patient outcomes over the last several years, but more progress is needed to increase long-term survival and improve quality of life.

Although the COVID-19 pandemic put a stop to many things, Mirati’s collective fight against cancer did not miss a beat. In 2021, Padres Pedal the Cause announced their annual event would be held virtually. Employees had the option to participate by joining a spin, yoga, or strength class offered by local fitness studios or by committing to the 100 percent challenge. Employees could also take part in an activity of their choice for 100 reps, 100 minutes or 100 miles, or any other challenge that was important to them. Mirati pledged 75 percent of its employees would participate with a total fundraising goal of $50,000.

Although virtual, the Mirati team found ways to collaborate and motivate one another to support the effort, including technological collaboration tools, weekly discussions to share engagement strategies and creative activities, including a silent auction. Most Mirati employees hiked, rode bikes, or swam to complete their 100 percent challenge.

Until each person with cancer has a therapy targeted to their disease, we will pursue our research with relentless focus for the next breakthrough.

“I am proud of Mirati’s efforts for this year’s Padres Pedal the Cause to support funding local cancer research,” Charles M. Baum, M.D., Ph.D., president and chief executive officer, Mirati Therapeutics, Inc. “As we work to bring life-changing medicines to patients with cancer, we are deeply committed to making a difference in the lives of patients and their families, our employees, and the communities with whom we collaborate and the neighborhoods where we live. Until each person with cancer has a therapy targeted to their disease, we will pursue our research with relentless focus for the next breakthrough.”

Mirati was named the largest corporate team of 2021 with 204 members, exceeding our employee participation goal, and raising over $74,000 for the event.

Mirati was the featured corporate sponsor in the Padres Pedal the Cause 2021 Honor Video, a video memorial composed of photos from cancer fighters, survivors and family members. Mirati was also named the largest corporate team of 2021 with 204 members, exceeding our employee participation goal, and raising over $74,000 for the event.

“On behalf of Padres Pedal, I am so thankful to Mirati for its outstanding partnership with our organization. One hundred percent of funds raised by Team Mirati and all other participants will go directly to fund life-saving cancer research in our community,” said Anne Marbarger, executive director, Padres Pedal. “Thank you, team Mirati, for honoring loved ones touched by cancer and fighting to improve outcomes for patients.”

About Cookies on This Site

This website uses cookies. Essential and functional cookies are necessary for the proper functioning of this website and cannot be refused. Other cookies are used for statistical purposes and will only be placed if you agree to their placement. For further details on cookies, how we use cookies and how to modify your choices regarding cookies, please read our Cookies Policy.